MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Gastrointestinal problemsm(also see autonomic dysfunction)"

  • 2025 International Congress

    DPPX Autoimmune Encephalitis Presenting with Chorea

    T. Le, S. Pradeep (Houston, USA)

    Objective: To report a case of a rare autoimmune disorder associated with dipeptidyl-peptidase-like protein- 6 (DPPX) antibodies, highlighting its classical features, diagnostic challenges, and therapeutic…
  • 2025 International Congress

    Impact of Gastrointestinal Dysfunction Symptoms on Psychomotor Recovery Following 8-Week Aerobic Interval Training in Parkinson’s Disease – Preliminary Results

    K. Lorek, K. Markowska, A. Bereza, E. Koziorowska, S. Budrewicz, P. Nowakowski, S. Chomiak (Wroclaw, Poland)

    Objective: To investigate the impact of gastrointestinal dysfunction symptoms (GIDS) on psychomotor recovery following 8-week aerobic interval training (AIT) in Parkinson's disease (PD). Background: GIDS…
  • 2025 International Congress

    NIH funds Gut-Brain Parkinson’s Disease Consortium

    C. Goetz, L. Becker, A. Bharucha, E. Chang, A. Keshavarzian, B. Kuo, K. Newby, K. Poston, L. Sanders, R. Savica, A. Sharma, A. Videnovic, L. Wruck, T. Xie (Chicago, USA)

    Objective: Describe the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) multicenter (UO1) Consortium on PD Gut-Brain Communication. Background: A 2024 Notice of Funding…
  • 2025 International Congress

    Turkish Validity and Reliability Study of the Gastrointestinal Dysfunction Scale for Parkinson’s Disease

    S. Irmak, H. Omercikoglu, D. Gunal (İstanbul, Turkey)

    Objective: The aim of this study is to make a Turkish adaptation of the "Gastrointestinal Dysfunction Scale for PD (GIDS-PD)"and detect gastrointestinal symptoms at an…
  • 2025 International Congress

    Helicobacter Pylori Infection, Peptic Ulcer, Gastritis and Risk of Parkinson´s Disease: a Nationwide Matched Cohort Study

    S. Licaj, A. Ploner, A. Szwajda, S. Hägg, F. Fang, J. Ludvigsson, K. Wirdefeldt (Solna, Sweden)

    Objective: To examine the potential link between H. pylori infection, gastritis, peptic ulcer and Parkinson’s Disease (PD) risk. Background: Gastrointestinal disorders are frequent among PD…
  • 2024 International Congress

    Altered gut microbiota composition and metabolism in Parkinson’s disease

    D. Mondhe, K. Roper, N. Jayabalan, J. O'Sullivan, R. Adam, A. Lehn, R. Gordon (Brisbane, Australia)

    Objective: To define changes in gut microbiota composition and metabolism to enable identification of novel therapeutic targets and strategies for disease modification. Background: Multiple cohort…
  • 2024 International Congress

    Exploring the Influence of Gastrointestinal Symptoms on Non-Motor Fluctuations in Parkinson’s Disease: Insights from the ReMePark-2, a Mexican Cohort

    A. Cervantes-Arriaga, AJ. Hernández Medrano, AL. Guerra-Anzaldo, A. Domínguez-García, DP. Romero-Terán, G. Rivera-Monroy, KI. Sánchez-Ramírez, MF. Medina-Pérez, M. Rodríguez-Violante, R. Baños-Betancourt, A. Abundes-Corona, SF. Arechavala Lopez, WF. Moguel-Cardín ()

    Objective: To determine the impact of gastrointestinal symptoms on NMF in PD among Mexican individuals living with PD (PwP). Background: The growing interest in the…
  • 2024 International Congress

    The Effect of an Exogenous Ketone Supplement on Gut Microbiota in Parkinson’s disease, a Pilot Study

    V. Vedam-Mai, M. Beke, V. Mai, P. Mackie, E. Klann, A. Gurrala, S. Chua, E. Ince, L. Almeida, A. Ramirez-Zamora (Gainesville, USA)

    Objective: To investigate the effect of exogenous oral ketone esters on gut microbiota in people with PD. Background: Mitochondrial dysfunction in the substantia nigra and…
  • 2024 International Congress

    Molecular Landscape of Gastrointestinal Dysfunctions in Parkinson’s Disease

    M. Lai, S. Kulkarni, B. Benitez (Boston, USA)

    Objective: Analyze multi-omics data from the PPMI cohort to identify molecular markers associated with self-reported gastrointestinal (GI) dysfunction in Parkinson's disease (PD) patients. Background: PD…
  • 2024 International Congress

    Comparison of Gastrointestinal Dysfunction in Early-onset and Late-onset Parkinson’s Disease

    C. Arora, N. Kamble, V. Holla, R. Mahale, R. Yadav, P. Pal (BENGALURU, India)

    Objective: To compare the gastrointestinal dysfunction in patients with early-onset Parkinson’s disease (EOPD) and late-onset Parkinson’s disease (LOPD). Background: Gastrointestinal dysfunction is one of the…
  • 1
  • 2
  • 3
  • …
  • 11
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28953 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley